Insulin plus growth factor inhibitor limits vision damage in diabetic mice


A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME).

Read more

Posted in Glucose & Insulin Medical Research Type I Type II